After the action today it should be clear without doubt orderflow is the superior methodology.
It’s not flip flopping like bipolar furus between limit down and Rippy of ages.
It’s balanced. Its objective. It’s fact and evidence based.
@SaiqueResearch Which makes complete sense, having the control as patients who would go through full covid-19 as opposed to patients dosed with forulumab. Give them time to make their case. Dont report misleading information. Much appreciated. Should i quote for E.g. their cash balance in bank.
@SaiqueResearch You clearly didn’t hear the interview with the CEO, did you? Do check it out, this is just an exploratory study, not a phase 2/3 trials. It was targeted for safety, any data beyond that was a bonus. Save you the time, it was targeted at early stage covid-19 patients.